BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling. Chao Angel et al. Journal of gynecologic oncology 2019 Oct

Genomics (A-Z)|Home|PHGKB




Last Posted: Jan 16, 2020

---

• BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling.
  Chao Angel et al. Journal of gynecologic oncology 2019 Oct
• Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors.
  Ryu Jai Min et al. Japanese journal of clinical oncology 2020 Jan
• Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer
  HK Kim, J Hum Genetics, January 2020
• Mayo genomic database to use sequencing for 100K participants
  G Slabodkin, Health Data Management, January 10, 2020
• Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer.
  Yoon Kyung-Hwak et al. Journal of breast cancer 2019 Dec 22(4) 587-598
• New PARP Inhibitor Approval for Pancreatic Cancer
  L Schlager, FORCE, January 6, 2020
• Black Women's Confidence in the Genetic Information Nondiscrimination Act.
  Sutton Arnethea L et al. International journal of environmental research and public health 2019 Dec 16(24)
• Increased Overall Mortality Even after Risk Reducing Surgery for BRCA -Positive Women in Western Sweden.
  Öfverholm Anna et al. Genes 2019 Dec 10(12)
• Latinas' knowledge of and experiences with genetic cancer risk assessment: Barriers and facilitators.
  Gómez-Trillos Sara et al. Journal of genetic counseling 2019 Dec
• Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.
  Gallardo-Rincón Dolores et al. Translational oncology 2019 Dec 13(2) 212-220

more